PARIS – Biogroup, the leading private medical laboratory services group in France and Belgium, has successfully completed through its two main subsidiaries the issuance of EUR800million in aggregate principal amount of senior secured notes due 2028 with a fixed interest rate of 3.375% and the issuance of EUR250m in aggregate principal amount of senior secured notes due 2029 with a fixed interest rate of 5%.
Back
